Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MRX-7EAT patch for shoulder tendonitis/bursitis
NCT01506154Phase 3Completed
- Sponsor
- MEDRx
- Start
- Dec 2011
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of etodolac + lidocaine in shoulder bursitis, sponsored by MEDRx. Started Dec 2011; status: completed.
02
Drugs
etodolac + lidocaine
03
Conditions
shoulder bursitis
Beyond the preview
Go deeper on NCT01506154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01506154.